The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer

Treatment for local and locoregional recurrence or second head-and-neck (H&N) cancers after previous radiotherapy is challenging, and re-irradiation carries a significantly increased risk for radiotherapy-rela...

Source: Radiation Oncology - April 16, 2020 Category: Cancer & Oncology Authors: Alexander R ühle, Tanja Sprave, Tobias Kalckreuth, Raluca Stoian, Erik Haehl, Constantinos Zamboglou, Roland Laszig, Andreas Knopf, Anca-Ligia Grosu and Nils H. Nicolay Tags: Research Source Type: research